Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 08, 2018 07:05 ET | Source: Assembly Biosciences

Assembly Biosciences Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

INDIANAPOLIS and SAN FRANCISCO, June 08, 2018 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ:ASMB) a clinical-stage biotechnology company advancing a new class of oral therapeutics for the...
June 04, 2018 07:00 ET | Source: Assembly Biosciences

Assembly Biosciences to Participate in Jefferies 2018 Global Healthcare Conference

INDIANAPOLIS and SAN FRANCISCO, June 04, 2018 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ:ASMB), a clinical-stage biotechnology company advancing a new class of oral therapeutics for the...
May 07, 2018 16:05 ET | Source: Assembly Biosciences

Assembly Biosciences Announces First Quarter 2018 Financial Results

INDIANAPOLIS and SAN FRANCISCO, May 07, 2018 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ:ASMB), a clinical-stage biotechnology company advancing a new class of oral therapeutics for the...
April 12, 2018 03:10 ET | Source: Assembly Biosciences

Assembly Biosciences Presents Positive Interim Data from Phase 1a and 1b Studies of ABI-H0731 in HBV Patients in a Late-Breaker Session at the EASL Conference

Robust antiviral activity observed in HBV patients Generally safe and well tolerated Planning underway for Phase 2a studies beginning summer 2018 Company to host conference call on Thursday, April...
April 10, 2018 17:40 ET | Source: Assembly Biosciences

Assembly Biosciences to Host Conference Call on April 12 to Review ABI-H0731 Interim Phase 1b Data in HBV Patients Featured in Late-Breaker Poster at EASL

INDIANAPOLIS and SAN FRANCISCO, April 10, 2018 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ:ASMB), a clinical-stage biotechnology company advancing a new class of oral therapeutics for the...
April 02, 2018 16:54 ET | Source: Assembly Biosciences

Assembly Biosciences Appoints Jackie Papkoff, PhD, Senior Vice President, Chief Scientific Officer Microbiome

INDIANAPOLIS and SAN FRANCISCO, April 02, 2018 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ:ASMB), a clinical-stage biotechnology company advancing a new class of oral therapeutics for the...
March 28, 2018 05:30 ET | Source: Assembly Biosciences

Assembly Biosciences Announces ABI-H0731 Phase 1b Interim Data Accepted as a Late-Breaker Poster at The International Liver Congress™ (EASL)

INDIANAPOLIS and SAN FRANCISCO, March 28, 2018 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ:ASMB), a clinical-stage biotechnology company advancing a new class of oral therapeutics for the...
March 12, 2018 07:05 ET | Source: Assembly Biosciences

Assembly Biosciences Announces Additions to Management Team and Board of Directors

INDIANAPOLIS, March 12, 2018 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ:ASMB), a clinical-stage biotechnology company advancing a new class of oral therapeutics for the treatment of...
March 05, 2018 07:00 ET | Source: Assembly Biosciences, Inc.

Assembly Biosciences to Present at Cowen’s 38th Annual Healthcare Conference

INDIANAPOLIS, March 05, 2018 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ:ASMB), a clinical-stage biotechnology company advancing a new class of oral therapeutics for the treatment of...
February 05, 2018 07:05 ET | Source: Assembly Biosciences, Inc.

Assembly Biosciences to Participate in Leerink Partners 7th Annual Global Healthcare Conference

INDIANAPOLIS, , Feb. 05, 2018 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ:ASMB), a clinical-stage biotechnology company advancing a new class of oral therapeutics for the treatment of...